Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up.

Leila El MatriAhmed ChebilKhaled El MatriYousra FalfoulZouheir Chebbi

Published in: Therapeutic advances in ophthalmology (2021)

Combining intravitreal injections of bevacizumab and MPL in the treatment of DME is effective and safe. This protocol may decrease the number of IVB and its frequency. It offers the advantage of lasting therapeutic response with fewer recurrences.

Keyphrases

metastatic colorectal cancer
combination therapy
randomized controlled trial
early stage
vascular endothelial growth factor
ultrasound guided
high resolution
age related macular degeneration
endothelial cells
study protocol